Neurescue

Series-A
neurescue.com Biotech & Healthcare
Total Funding $7.2M
Latest Round $7.2M Series-A
Last Announced Feb 5, 2024
Investors Undisclosed
Decision Makers 5 Available

About Neurescue

The First and Only Treatment Approved for Non-Shockable Cardiac Arrest CE Marked (NB 2443)

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website neurescue.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $7,230,000 · Series-A

    startupintros.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Neurescue.

Funding History

1 Round
Series-A equity · Feb 5, 2024

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts